How Fast Do NAD+ Strips Work? An Honest Timeline

In this article
Short answer: The fastest verified signal here is genuinely fast: in a company-announced rat pharmacokinetic study, sublingual NAD+ peaked in the blood within 10 minutes. A nine-person human pilot reported average blood NAD+ rises of +59% at two weeks and +76% at six. Felt effects are a separate, slower question.
Timeline questions invite invented timelines, so this page does the opposite: every statement is anchored to a named piece of evidence, tagged by tier. Molecule background lives in the NAD+ guide; the daily routine in how to use NAD+ strips.
The minutes-scale anchor — sublingual delivery is built for speed
The rationale for the strip format is speed: the tissue under the tongue is thin and richly supplied with blood vessels, so compounds that absorb there can reach circulation without waiting on digestion. The general mechanics are in how fast sublingual delivery works.
And the one direct measurement in the category supports the fast-onset story: iX Biopharma's SL-NAD+ program announced a rat pharmacokinetic study (18 Sprague-Dawley rats, LC-MS/MS measurement) reporting mean peak plasma NAD+ at a two-fold increase within 10 minutes of sublingual dosing [preclinical evidence]. The company also claimed sublingual bioavailability around 22% versus IV — we quote that strictly as the company's claim [brand claim — unverified]. Rats aren't humans and a different manufacturer's wafer isn't this strip, but the study demonstrates the route can move NAD+ into blood quickly in a living model.
The weeks-scale anchor — the human pilot
The same program announced a human pilot in July 2024: nine healthy individuals, open-label, company-sponsored. Whole-blood NAD+ rose on average +59% at two weeks and +76% at six weeks versus baseline [brand claim — unverified]. Two things are true at once here: these are real measurements in real humans, and the trajectory — measurable movement by week two, more by week six — is the encouraging part; the design (no placebo arm, nine people, sponsor-run, not peer reviewed) is why we present it as reported, not proven.
What users commonly report
Users frequently ask when they'll "feel" something, and the attributed pattern in user discussions tracks the pilot's shape: many users describe noticing a difference in day-to-day energy within the first couple of weeks of consistent daily use, with the effect feeling more established around the one-month mark (attributed user reports, unquantified). The near-universal caveat in those same discussions is consistency — the users reporting the most are the ones who never miss the morning strip.
The honest limits, once
One passage, then done: no controlled human onset or outcome trial exists for sublingual NAD+ strips, and this specific product has never been measured in any study — the anchors above belong to a different company's wafer program, and whether felt effects track blood levels at all is unproven. We'd rather you know exactly which rung of the ladder each claim stands on. The safety ledger is covered with the same candor at NAD+ side effects.
Route context — why timelines online look so different
NAD+ timelines across the internet are usually imported from IV clinics, where blood levels rise immediately by definition, or from oral-precursor studies (NR/NMN) — different molecules that raise blood NAD+ through the gut, with human trials at 250–1,000 mg/day roughly doubling blood NAD+ over weeks of use. Intact NAD+ doesn't survive digestion, which is precisely why the sublingual route is being explored. A strip of intact NAD+ is its own thing, with the rat PK and pilot data above as its actual evidence base.
The bottom line
The honest timeline is more encouraging than skeptics expect and more modest than marketers claim: the route has demonstrated rapid blood-level movement in an animal model (peak ~10 minutes), a human pilot reported rising levels by week two and more by week six, and users commonly report the felt version follows that same weeks-scale arc with daily consistency. If a month-long, one-strip-a-morning trial sounds like a reasonable way to find out for yourself, the NAD+ strips are $118 per 30-strip box, in stock. Questions about your personal situation belong with a licensed provider.
---
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.
Reviewed by counsel against FDA structure/function guidance.
how long does sublingual NAD+ take to work — quick answers
How long does sublingual NAD+ take to work?
The anchors: a rat study showing peak blood NAD+ within 10 minutes of sublingual dosing [preclinical evidence], and a nine-person uncontrolled pilot reporting average rises of +59% at week 2 and +76% at week 6 [brand claim — unverified]. No controlled human trial exists for this product.
How fast do NAD+ strips absorb?
The only pharmacokinetic measurement in the category is the company-announced rat study (peak ~10 minutes). Cross-species and cross-product, it suggests rapid absorption is possible through this route — it's encouraging, not conclusive.
When will I feel NAD+ strips working?
Users commonly report noticing a difference within the first couple of weeks of consistent daily use, feeling more established around a month (attributed user reports, unquantified). There's no controlled data tying felt effects to any week.
Is sublingual NAD+ faster than oral?
Intact NAD+ doesn't survive the gut, which is the rationale for trying the sublingual route. No head-to-head human comparison exists, so "faster" is a well-reasoned hypothesis supported by animal PK data — not yet a human finding.
Educational content. This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.
FDA disclosure. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
The honest peptide brief
One email a month: new research on the compounds we cover, new lots and COAs, and zero hype. Unsubscribe anytime.
We never sell your address. 18+ only.


